Posts Tagged FDA

Osteoporosis: the FDA, the U.S. agency, launches the alert on anti-osteoporosis

The FDA, Food and Drug Administration, U.S. agency responsible for public health, is launching a new alarm: some anti-osteoporosis drugs belonging to the class of bisphosphonates can cause severe pain in the muscles and bones.
“The judgments are followed by FDA’s various realities of the health and nutrition, as has historically been characterized for its role in protecting consumers of therapeutic substances to push through federal legislation on vaccines.

This time the drugs “accused” by the FDA are some of those used to treat ‘s osteoporosis and are called: risedronate, pamidronate, ibandronate, Etidronate, alendronate, zoledronic acid and tiludronic. It’s been shown that people treated with these types of medicines developed crippling pain in bones, joints and muscles. Despite the likelihood of accusing severe musculoskeletal pain is stated in the material attached to the medicine, the FDA stresses that such distress should be monitored by health professionals who should provide the administration with great caution.

The alarm is the probability that the association between the use of bisphosphonates and musculoskeletal pain may interfere with the effectiveness of anti-osteoporosis therapy, or necessitate the recruitment of analgesics. In some cases it was verified that the side effect occurs within the first days of treatment, others after months or years. The study tested how the FDA has in some cases, suspension of treatment corresponded to the disappearance of pain in others there has been an improvement in others slow and incomplete.

Professionals are well known of these effects, in fact, advance notice to the patient before administering the treatment. But cause for these effects are still unknown and the type of information the FDA, which was launched as an alert is given to doctors to assess your case the conditions of their patients and, if appropriate, take into consideration the discontinuation of therapy. Furthermore, the FDA is also addressed to warn patients not to discontinue the therapy itself, would be a grave mistake to do it without your doctor’s advice.

, , , , , , , , , ,

No Comments